The global surgical laser market size was estimated to be US$ 6.3 Billion in 2022 and is expected to reach US$ 18.1 Billion by 2032 at a CAGR of 11.1%.
Rapid technological advancements in healthcare industry, coupled with high prevalence of chronic diseases such as, ophthalmic disorders and heart surgeries are expected to drive industry growth over the coming years. Additionally, the sharp increase in number of minimally invasive surgeries performed each year is further fostering market demand for surgical lasers.
Developing economies including, Mexico, Brazil, China and India are witnessing rising healthcare expenditure and increasing per capita income, leading significant growth in region. Other factors contributing to the growth include rising target population and high prevalence of eye disorders.
Major players dominating the global market include Abbott Laboratories, Inc., Boston Scientific Corp., BISON MEDICAL Co., Ltd., Biolitec AG, Alma Lasers Co., Photomedex, Inc., and Lumenis Ltd.
The report titled “Surgical Lasers Market - Global Market Share, Trends, Analysis and Forecasts, 2023-2032” wherein 2021 is historic period, 2022 is the base year, and 2023 to 2032 is forecast period. Additionally, the study takes into consideration the competitive landscape, wherein the report would provide company overview and market outlook for leading players in the global surgical lasers market. Furthermore, the report would reflect on the key developments, global & regional sales network, business strategies, security & exchange overview, research & development activities, production facilities, product portfolio, employee strength, and key executive, for all the players considered under the scope of study.
For instance, Abbott Laboratories, Inc., reported revenues of US$ 30.78 Billion in 2018 and the segment and geographic analysis of the company indicates that Cardiovascular and Neuromodulation is the dominating revenue segment of the company, with the North America being the major revenue generating region.
The surgical lasers market study takes into consideration market segmentation based on type, product type, application, and geography. Based on type, the market is segmented into carbon dioxide (CO2) lasers, argon lasers, ND:Yag laser, diode lasers, solid state laser and other. Based on product type, the market is segmented into open surgery, laparoscopic surgery, and percutaneous surgery lasers. Based on application, the global surgical lasers market is segmented into ophthalmology, dermatology, dentistry, urology, cardiology, gynecology, and oncology. On the basis of geography, the market is segmented into North America, Europe, Asia Pacific, South America, and Middle East & Africa.
The study provides in-depth analysis of individual company considered under the scope of study with a focus on all operating business segment, and would identify the segment of the company focusing on surgical lasers. Further, market share of company in the global market would also be calculated. For instance, NovaMed, Inc. (NASDAQ:NOVA)(“NovaMed” or the “Company”), a leading operator of ambulatory surgery centers in partnership with physicians, announced that it has entered into a definitive merger agreement to be acquired by an affiliate of Surgery Center Holdings, Inc. (“Surgery Partners”) in a transaction valued at approximately $214 million, including the assumption or repayment of approximately $105 million of indebtedness.
The report study takes into consideration the key competitive information such as business strategy, product portfolio, key development, SWOT analysis, and research and development focus of all the surgical lasers companies. Furthermore, the global surgical lasers market study would take into consideration the participants engaged throughout the supply chain and value chain of the market, along with their contribution. Product portfolio would focus on all the products under the surgical lasers business segment of the company. Similarly, the recent development section would focus on the latest developments of company such as strategic alliances and partnerships, merger and acquisition, new product launched and geographic expansion in the global surgical lasers market.
For instance, Abbott Laboratories, Inc. operates through five segments namely Pharmaceutical Product, Nutritionals, Diagnostics, Cardiovascular and Neuromodulation, and Others. Moreover, the company offers Surgical Lasers under the Cardiovascular and Neuromodulation business segment which generated a revenue of US$ 9,437 Mn in 2018.
Market Segmentation:
By Type
By Product type
By Application
By Region
The surgical laser market size is expected to reach US$ 18.1 Billion by 2032.
The surgical laser market is expected grow at a CAGR of 11.1% from 2023 to 2032.
The surgical laser market size was estimated to be US$ 6.3 Billion in 2022.
Rapid technological advancements in healthcare industry, coupled with high prevalence of chronic diseases such as, ophthalmic disorders and heart surgeries are expected to drive industry growth over the coming years.
Surgical Lasers are largely used in the ophthalmology, dermatology, dentistry, urology, cardiology, gynecology, and oncology.
The major active players are Abbott Laboratories, Inc., Boston Scientific Corp., BISON MEDICAL Co., Ltd., Biolitec AG, Alma Lasers Co., Photomedex, Inc., and Lumenis Ltd.
The base year considered in Surgical Lasers market report is 2022.
Copyright © 2024 Same Page Management Consulting Pvt. Ltd. (insightSLICE) | All Rights Reserved